RA Capital Management, L.P. 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-14 4:03 pm Sale | 2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 0 0.000% | -9,040,309 (Position Closed) | Filing |
| 2022-09-02 4:30 pm Purchase | 2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,040,309 18.880% | 11,125 (+0.12%) | Filing |
| 2021-10-28 4:32 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,029,184 19.050% | 17,533 (+0.19%) | Filing |
| 2020-06-25 5:02 pm Purchase | 2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA Capital Management, L.P. | 9,011,651 23.400% | 9,011,651 (New Position) | Filing |